Savara Inc stock is traded at $4.26, with a volume of 17,008,338. It is down -18.23% in the last 24 hours and down -10.50% over the past month. Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Previous Close:
$5.21
Open:
$4.19
24h Volume:
17,008,338
Relative Volume:
2.72
Market Cap:
$939.86M
Revenue:
-
Net Income/Loss:
-$129.48M
P/E Ratio:
-
EPS:
-$0.5584
Net Cash Flow:
-$106.97M
1W Performance:
-8.19%
1M Performance:
-10.50%
6M Performance:
-16.14%
1Y Performance:
-8.78%
1-Day Range:
$4.00$4.52
1-Week Range:
$4.00$5.34
52-Week Range:
$4.00$7.01
Savara Inc Stock (SVRA) Company Profile
Name
Savara IncSector
HealthcareIndustry
BiotechnologyPhone
51285113796Address
6836 BEE CAVE ROAD, AUSTIN, TX, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS